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Met/to&: In 18 1 otionts spANA WOR portarmed allor completion of rou. 
tine pRNA. Twolvo psllants woro tranlod wilh cnrdlotoxlc nganls. 5 pnllQnl8 
wero known with R p:~wlous myocnrdlnl InIflrcllon, 1 pnllont was known wllh 
dllntod cnrdlomyopnlt~y. For GpRNA n J.hend gnmmn cnmorn wna used. 
Allor Illlarln~ of data short, horlronlol long nnd vorllcal long nxos wore r& 
construdsd lmm 2 pixel thick transverani sllco%. SPECT EFs wore nsstwsad 
by npplylng a 35% lhrcahold la a roglon canlolnln(d lho LV. 0n pl.RNA and 
ap.RNA Gtudlos mgionnl WRII motion (normnl, hype., aa or dysklnssln) wna 
vlaually rsea~aod In 7 myocordlnl ao~monla. For the afiflossmunt o! Inlra- 
Gnd lnlar abaotvor vnrlnblllty spRNA EF mGqGuremanlG were parlormad 
twica by the ranma obsorvar and onto by n eocand abaarvar. 
f?@~wlfa: Qn @*RNA wnll motlen Gbnormnlltlaa wore abaarvod in 12 Gap 
msnlr (wgm), Qn e-RNA 15 Ggm worn canslldarcd obnarmal, In 0 agm nbnor. 
mallli@w orn canaldarad maru @ivera an spRNA than an pl.RNA. In lha 12 
pnllsnls tmnlad wllh cnrdlalowia nganls no wqll mollan nbnonnlllloa wnm 
ob8elvad. 
Thcra was G llnonr rafnllonshlp balwaan PI-RNA and GpRNA EF men, 
Gulsmonta (y a I( + 6.8: r 9 0.83: BEE m R,O). The Inlrn., and Inlor.abaorver 
varlnbllltloa warn 1 .R9h t 2J3 nnd 3.296 + I.Q?b raspocllvnly, 
f%~~~r~lon: spRNA la nn nccwMo mslhod lar !ho ntxwmmonl al LV 
tunallan. The (lain al SPECT In RNA Is the impmvad daloclion ol ru@annt 
wnll mollan nbnormnllllor\. 
DobuWnlnc ntsdSPECT, thallhnn-SPECT and 
Oobutamlna t trasa Echocardlogrnphy to Assess 
Myoaardkl Vlablllty 
N Dnmdoa, .I. Monloli. 8. Varhaka, I! Virot, ,l.C Vnndmux Ltmogtxi 
l!fln~cac Hosp&lI. mrnce 
Atm: II Accuracy at MIBtQuonntR\wo.G~~od.SPECt (OG.SPECT) duung 
dobutr\mlnn Inluslon. la ARBORR myaanrdlnl vlohilily dalormlncd by dabu, 
lnmlns ntru~a ochoonrdlogmphy. 2/ Compadacn 01 QQ.SPECT dnln, LV 
volume, n]nclton lrncllan (LVEFI. wnll mollon nnd thtcksnmg. wllh echncnr~ 
dlo~ruphy nnd LV nnglo~rnm. 
Mefho~Y.% R doubln hond rolnlad gnmmo cnmarn (HELtX~ELSCINT wllh 
Cedara Slnm sottwam\ was uned to padorm QC&SPECT. 12 ptn had myacnr. 
dml vlnblllty 8htdlad by Thnlllum~SPECT and dunng dobulnminn rnfusmn (IO 
rdg.kg ’ .mn ’ j by QCI~SPECT nnd slros.~ cchocnrdloarnphy (dobu-echo) 37 
pls got QGZiPECT wllh ochocnnilography nnd coronary nnglography 
Rnstrl?x II OG-SPECT ovorvn1uns bnsnl LV volumns (dmsl. +12x sysl. 
+Xt?b) nnd undorrnlcs LVVEF ( 20%). During dobulnmme mluslon. LVEF 
chnn(las sm wclll cormlnlod wllh cchocnrdloQraphy dnln (r i 0.88). 2! Kmokc 
Rbnofmallllns of LV nnglcgrams nm wall doler’nrl by ochocardicaraphy (sons 
94% spec. 87%) Qr&SPECT dotoclton accuracy ,s lowor (sans = 92%. spcc 
50%). ~3 GIG ZPECT IS bcllor Ihn, f thollntm~SPECT lo detccl a myocardlal 
vlnblllty In mlarckon nmn 
Concrusion: CtQ-SPECT IS a qunnlitatlvo automatic mathod. II IS lcas~ble 
during R dotxllamino mtuston. Dobulamlno QQ-SPECT is a now way to 
Gssoss myocnrdln~ vinbllity. 
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1 1234-47 1 Assoclatlon ot Accelerated Atherosclerosis and 
Myocardlal Hypertrophy With Systemic Lupus 
Erythematosus 
M.J. Roman. J Salmon. Ft. Sobel. L. Sammarilano. R.B. Devereux. 
M.D. LockshIn. Cornell Unrvers~fy Medical College and Hospital for Spenal 
Surgery New York. New York. USA 
BacIrgmun@ Clrnlcal evidence of pmt..alure vascular disease (stroke and 
myocardinl Infarction) has been reported in systemic lupus erythemalosus 
(SLE) and antlphosphokptd antibody syndrome (APLA) and has been al- 
tdbuted to an increass in convenllonal slherosclerosis risk factors and/or 
prednisone use. 
MelhodS: Preclinical evidence of vascular and myocardial disease was 
evaluated Using carokd and cardiac ullrr” :ound in 18 patients with SLE and 4 
wrlh prlmaly APLA and compared to knatngs !n 44 control subjects matched 
for ago (moan E 41 years), gonder (100% tcmnlo) nnd race and lo the 
prosonca of risk factors. 
R~ssulls: Pntionts ware campamble lo conlrats in blood prossuro. totnl and 
HDL cholastoml, nnd smokmg hlalory but tended la bo obese (body mnes 
lndox 29.3 va. 25.2 kQlm2, p = 0.05). Provalence ot cnmltd plnquo was hl(lhar 
In pttIlanta (41 vs Er%, p < 0.005) nG was tell venrtncular (LV) mass ad~usleci 
for absslty (40.3 va 318 gmlm” I, p .: 0.005). Furthatmors them wem no 
dlHemncea batwaen pallontG wllh nnd wlthout plaque In convsnltonal risk 
Inclara or us@ al prsdnlseno, PIttqua nnd/ar LV hyporlrophy WRI pmsent m 
617 pwlionta with cllnlcal cnrdlovasculnr dlaaase. 
Conc/u.e/onona~ Pracllnlcal oard~cvosculor disaasa 18 vary cemmorr m SC6 
Rnd APM and 18 nat axplnmad by tmdilrannl ab fndam or .@orwd UBR, 
auagaellnn that Inllommnlien p@er BO may be al ptimwy Impsflanw 
Euhocardlography ’
Ondgmund Wa aou~lrl la valrdnlo n simple Bayeslan model of asscasmq 
nak ot polop cardmc dnz\\h or M\ In vascular surgery. We exammed the 
USC cl dobulamino a~rosa echo (DE) rosulls to replace drpyndamote-thalltum 
ecinltrtraphy (DTHAL) as the cJk?gnoskc tar compulmg a secondary nsk score 
M@tho&: Data wore colkxlcd lor 340 pallenls (PTS) mcl~$ng clintcat 
nnd atress lest markers tdanltticd by Cllaltan. A taglstrc model ~ncnrparzlted 
ago -?O years, nngma, hIstory al MI. diabetes melktus (D&Q. h@sloty of 
congostwa hoart tailurn (CHF) and pnor ruvascuk%nraGon to ebtanr dintea\ 
nsk calimnles. Wa added DE msulls (1.0. fired and mverslbte wall moron and 
ST changes) IQ cmnlo a second 1~1611~ model. Compansan cl observed and 
pmdtolod ostimalcs al cardiac events and recewcr opemtmg chamclenslrcs 
tAOC1 curves were used lo assess fho models 
Rosurfs. The postop cafdlac event rat0 WBS 7% (241340). The event rate 
cslimalcd tram lhc clmtcnl modal was 5.6%; addmg DE Imndmgs PI&C&XI 
nn oven1 ralo ol7.49.. Tha cbsotved event rate in PTS da&ad by ckrwcal 
dnln as low (O-5%). modonta (--5-15%). or high nsk ( .15%) were 3 P.. 
106%. and 14.3% Adding DE resulls reclassilred PTS horn ali car~nes 
wllh the obsorvcd event rate tn low. moderato or high nsk PTS of 1 .P,. 7 O”., 
and 25.5%. The ROC curve (ama .t30”0) Ior adverse event predictan usmg 
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Conchrsron: We vakdalcd a Bayesran method for assessmg cardfac rtsk 
In vascular surgery. The use cl of DE lo replace DTHAL dtd not reduce the 
preclsron at the model. The clmtcal model IS rekable m a malcrlly 01 PTS: 
whtle DE can help to lurihor relme nsk predtclton lor specllic cknrcal nsk 
Correlation Between pre and lntraoperative 
Myocardlal lschemia in Patients Undergoing 
Ma]or Vascular Surgery Detected by Oobutamine 
Stress Echocardiography and Continuous 
12.Lead Electrocatxliography 
D. Pcldermans. S. Mcy. A.M. Pclerse. RF. Veldkamp. K Leendertse. 
H. van Urk. P. Klcolwllk. Erasmus Unwersify Rotter&m. The Nerherlands 
Aim of the Study To compare myocardial tscnerma delectod prcoperalively 
wllh dobutamine sbess echocardiography (DSE) with intraoperahve achema 
usmg continuous 12.lead EGG (Eli-100 ST) (ECG) monllonng in pls under- 
gomg major vascular surgery. 
Methods. DSE was used m 58 pls tor the presence and location of stress 
Induced ischemia (NWA). ECG monitoring started 12 hr before up to 36 hr 
a!lor surgery In or&r lo analyse the “ischemrc burden” and location (ante- 
rior. laleral. inferior. and posterior). an algorithm was used for the detectron 
and quantification of ischemic ST.episodes in each ot Ihe 12qleads ECG 
separately. Total ischemic burden was calculated as the total duration of ST- 
eptsodes (min) per pl and the summaled areas (severily) under the curves 
of the 12-leads episodes (,lV.min). 
Resu/ts: ECG ischemia was preceded by a mean heart rate increment of 
51 “b. DSE and ECG showed ischemia in 1 X.6 and 25156 pls. The agreement 
